Immunotherapy in renal cell carcinoma: latest evidence and clinical implications

Advances in understanding the mechanisms of tumour-induced immunosuppression have led to the development of immune-checkpoint inhibitors in cancer patients, including those with renal cell carcinoma (RCC). The optimal combination between immunotherapy and targeted agents (as well as the possible fav...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drugs in Context 2018, Vol.7, p.212528-8
Hauptverfasser:	Santoni, Matteo, Massari, Francesco, Di Nunno, Vincenzo, Conti, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Montironi, Rodolfo, Cheng, Liang, Battelli, Nicola, Lopez-Beltran, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	immunocheckpoint inhibitors immunotherapy PD-1 renal cell carcinoma tyrosine kinase inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!